Dr. Ryan Kennedy, DNP

Comprehensive Psychiatric Evaluation:

• Diagnostic clinical interview

• Developmental and academic history review

• Functional impairment assessment

• Collateral information from parents/teachers, 

• Developmental history (children/adolescents)

• Family psychiatric history

• Academic or occupational functioning

• Psychosocial and environmental factors

• Medication history and treatment response

• Diagnostic formulation using DSM-5-TR criteria

 

Common concerns:

• ADHD and executive functioning difficulties

• Anxiety disorders (GAD, social, separation, panic)

• Autism spectrum–related psychiatric comorbidities

• Behavioral concerns in children

• Depression

• Bipolar spectrum disorders

• Emotional dysregulation

• OCD & related problems

• Sleep disturbance

• Substance use (adolescents and adults)

• Suicidal ideation & safety assessment (outpatient level)

• Screening and referral for higher risk/level of care: schizophrenia, eating disorders, SI, Bipolar 1, BPD

​

Psychiatric Medication Management:

Evidence-based pharmacologic and non-pharmacologic treatment and monitoring.

 

Services include:

• Medication initiation and titration

• Monitoring of efficacy and side effects

• Treatment adjustments over time

• De-prescribing medications to challenge efficacy and risks

• Integration of medication with therapy

 

Medications commonly managed:

• Anxiety medications 

• ADHD medications (stimulant and non-stimulant)

• Antidepressants

• Antipsychotics

• Mood stabilizers

• Sleep medications

 

Clinical Documentation & Reports:

Preparation of clinical documentation when appropriate.

 

Examples include:

• College or graduate school accommodation documentation

• ADA accommodation letters

• Executive functioning evaluation summaries

• Treatment summary reports

• Coordination letters for schools or other providers

 

Medical and Laboratory Monitoring:

 

When clinically indicated:

• Medication safety labs (metabolic, liver, thyroid, etc.)

• Medical screening when symptoms suggest underlying conditions

• Targeted pharmacogenetic enzyme testing in select cases of atypical medication response

 

When Referral To Dr. Ryan May Be Helpful:

 

Therapists may consider referral when:

• ADHD diagnosis or medication evaluation is needed

• Symptoms suggest mood instability or bipolar spectrum illness

• Anxiety or depression significantly impair functioning

• Medication consultation may enhance therapy outcomes

• Executive functioning difficulties limit progress in therapy

• Diagnostic clarification is needed

 

Collaborative Care Approach:

Treatment is coordinated with referring therapists when appropriate.

 

Collaboration may include:

• Diagnostic clarification

• Medication consultation

• Shared treatment planning

• Monitoring functional progress

• Communication regarding symptom changes or treatment response